)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Arcoma
Arcoma (ARCOMA) investor relations material
Arcoma Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary22 Oct, 2026
Executive summary
Q3 revenue was SEK 26.2m, down from SEK 29.9m YoY, while EBITDA rose to SEK 4.1m from SEK 3.9m; EBITDA margin improved to 16% from 13%.
North America grew 11% YoY and was the strongest market; European sales fell 25% amid uneven investment activity and longer customer decision cycles.
Financial highlights
Q3 gross margin was 45.7%, up from 41.3% YoY; EBIT was SEK 2.9m versus SEK 2.0m, and net income was SEK 2.4m versus SEK 1.6m.
Q3 profit before tax was SEK 3.0m versus SEK 2.0m; EPS was SEK 0.16 versus SEK 0.11.
9M revenue was SEK 89.0m versus SEK 96.1m; EBITDA was SEK 7.9m versus SEK 10.2m, net income SEK 3.5m versus SEK 3.6m, and EPS SEK 0.24 versus SEK 0.25.
Outlook and guidance
Entering Q4 with a balanced market view; focus remains on strengthening sales across priority markets, with long-term demand drivers in diagnostic imaging described as strong.
New camera-based workflow features are in development and expected to launch in Q4; continued product-development investment and partner activity are intended to support future growth.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Arcoma
- North America drove 16% sales growth in Q2 2026, supporting stable results and strong cash position.ARCOMA
Q2 2026 - Q1 revenue fell 11% but profitability and strong cash position were maintained.ARCOMAQ1 2026
- Profitability and strong cash flow in 2025, with growth in Europe but declines in other regions.ARCOMAQ4 2025
- Q3 saw stable margins and strong US growth, but overall sales and profit declined year-over-year.ARCOMAQ3 2025
- European growth offset by sharp declines in US and Asia; profitability maintained via cost control.ARCOMAQ2 2025
- Stable EBITDA and strong aftermarket growth offset lower Q3 sales; debt fully repaid.ARCOMAQ3 2024
- Q2 sales up 9%, EBITDA up 103%, with strong growth in North America and Asia.ARCOMAQ2 2024
- Record profit and improved margins in 2024, with strong financial stability and growth outlook.ARCOMAQ4 2024
- Revenue fell but margins and European growth offset US delays; outlook remains positive.ARCOMAQ1 2025
Next Arcoma earnings date
Q4 202611 Feb, 2027
Arcoma
Next Arcoma earnings date
Q4 202611 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Arcoma AB is a medical technology company based in Sweden, specializing in the development, production, and marketing of digital radiographic systems. These systems incorporate digital imaging technology and advanced mobile positioning systems, designed for use in various medical settings including hospitals, clinics, imaging centers, and private practices. Arcoma's product offerings encompass complete radiographic systems, which are available in configurations such as ceiling suspensions and floor-mounted systems. Additionally, the company provides a range of radiographic system components, including overhead tube cranes, cubes, tilting wall stands, and radiographic tables, along with mobile imaging tables in two series: Precision and Elite. These products are distributed through three main channels: the company's own brand IMIX, private label distributors, and original equipment manufacturers (OEMs). The company is headquartered in Växjö, Sweden, with its shares listed on the Stockholm Stock Exchange.